Table 21:
Budget Impact Analysis Results—Scenario Analyses
| Scenario | Budget impact, $ milliona | ||||||
|---|---|---|---|---|---|---|---|
| Year 1 | Year 2 | Year 3 | Year 4 | Year 5 | Totalb | % Changec | |
| Reference case | 0.51 | 1.01 | 1.53 | 2.06 | 2.61 | 7.73 | 0% |
| 1. Low volume of localizations | 0.46 | 0.91 | 1.37 | 1.82 | 2.28 | 6.84 | -11% |
| 2. High volume of localizations | 0.55 | 1.11 | 1.70 | 2.31 | 2.94 | 8.61 | 11% |
| 3. Increased uptake of wire-free, nonradioactive localization techniques | 0.63 | 1.27 | 1.92 | 2.59 | 3.28 | 9.70 | 26% |
| 4. Decreased uptake of wire-free, nonradioactive localization techniques | 0.38 | 0.75 | 1.14 | 1.54 | 1.94 | 5.75 | -26% |
| 5. Manually loaded radioactive seeds | 0.53 | 1.06 | 1.61 | 2.18 | 2.76 | 8.14 | 5% |
| 6. Capital expenditures scenario at a representative site | 0.56 | 1.11 | 1.68 | 2.26 | 2.86 | 8.47 | 10% |
| 7. Capital expenditures scenario at a high-volume site | 0.54 | 1.08 | 1.63 | 2.19 | 2.77 | 8.22 | 7% |
| 8. Capital expenditures scenario at a low-volume site | 0.62 | 1.23 | 1.85 | 2.49 | 3.15 | 9.34 | 21% |
| 9. Different re-excision rate for each localization technique | 0.31 | 0.62 | 0.93 | 1.25 | 1.58 | 4.69 | -39% |
| 10. Higher cost to acquire wire-free, nonradioactive markers or seeds | 0.62 | 1.25 | 1.89 | 2.54 | 3.21 | 9.51 | 23% |
| 11. Lower cost to acquire wire-free, nonradioactive markers or seeds | 0.39 | 0.78 | 1.18 | 1.59 | 2.01 | 5.95 | -23% |
| 12. Replacing biopsy clip placed after core biopsy with MRI-compatible wire-free, nonradioactive marker or seed | 0.49 | 0.99 | 1.49 | 2.01 | 2.54 | 7.53 | -3% |
In 2022 Canadian dollars.
Results may appear inexact due to rounding.
Percent change calculated as the total budget impact of the scenario analysis divided by the total budget impact of the reference case.